Alvotech (ALVO) vs Immunome, Inc. (IMNM)

A side-by-side comparison of Alvotech and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alvotech logo
ALVO
Alvotech
$2.07B
$6.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Immunome, Inc. logo
IMNM
Immunome, Inc.
$2.02B
$21.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ALVO vs IMNM

growth of $100 · dividends reinvested · last 4y
ALVO -45.4% (-14.0%/yr)IMNM +612.8% (+63.4%/yr)IMNM compounded faster over this window
Log scale — wide-divergence pair
101001kStart $1002023202420252026$55$713
ALVO IMNM

ALVO vs IMNM: by the numbers

  • •ALVO is the larger company ($2.07B vs $2.02B market cap).
  • •Both run net losses; ALVO's is the smaller (-36.51% vs -3059.99% net margin).

Metrics side by side

Valuation

MetricALVOIMNM
P/S ratio4.20N/A
P/B ratioN/A3.85
EV / EBITDA41.84N/A

Profitability

MetricALVOIMNM
Gross margin60.45%57.43%
Operating margin9.62%-3084.76%
Net margin-36.51%-3059.99%
ROEN/A-48.43%
ROIC3.61%-51.06%

Growth (annualized)

MetricALVOIMNM
Revenue CAGR (5Y)69.03%N/A
Total return CAGR (5Y)N/A2.88%

Go deeper

Full ALVO analysisFull IMNM analysisInteractive comparison tool

Dig into the metrics

Alvotech ROEImmunome ROEAlvotech operating marginImmunome operating marginAlvotech revenue growthImmunome revenue growthAlvotech free cash flowImmunome free cash flow

Alvotech & Immunome appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.